Skip to main content
. 2012 Apr;23(4):652–660. doi: 10.1681/ASN.2011040369

Figure 5.

Figure 5.

Effects of a selective ETA receptor antagonist ambrisentan on SBP, UAE, and CCr. (A) Ambrisentan significantly decreases SBP of WT sFlt-1 and eNOS−/− sFlt-1 mice. (B) Ambrisentan decreases daily UAE more in eNOS−/− sFlt-1 mice than in WT sFlt-1 mice. (C) Ambrisentan increases CCr in eNOS−/− sFlt-1 mice. n≥5 for each group.